Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut microbiota composition and metabolites describe the diverse population of microorganisms residing in the gastrointestinal tract and the wide array of molecules (e.g. short-chain fatty acids, bile acids, phenolic compounds) they produce through dietary fermentation, host compound transformation, and direct biosynthesis. These microbial metabolites have profound effects on host health, affecting metabolic processes, immune regulation, neurobiology, and disease development. Therapeutic strategies increasingly focus on modulating gut microbiota composition or targeting specific microbial metabolites, as growing evidence connects these with insulin resistance, cancer, neurodegenerative diseases, cardiovascular pathologies, and other systemic conditions.
Modulation of metabolic pathways (e.g. increased production of beneficial SCFAs); Restoration of microbial community balance (reduction of dysbiosis); Inhibition or activation of host receptors, e.g. GPCRs (via microbial metabolites); Alteration of host gene transcription (via HDAC inhibition)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota composition and metabolites (null).